Investigational Site Number 840001 — Kansas City, Kansas

Investigational Site Number 840001 is a clinical research site located in Kansas City, Kansas, United States 66160-7321.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

Investigational Site Number 840001 has participated in 3 clinical trials.

Therapeutic areas: Hematopoietic Neoplasm, Glycogen Storage Disease Type II Pompe Disease, Pompe Disease.

Sponsors: Bristol-Myers Squibb, Genzyme, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840001?

Investigational Site Number 840001 has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840001 conducted?

Investigational Site Number 840001 has 3 clinical trials on record. Their work covers Hematopoietic Neoplasm, Glycogen Storage Disease Type II Pompe Disease, Pompe Disease.

Is Investigational Site Number 840001 accredited by Crixeo Health?

Investigational Site Number 840001 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840001?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.